Dr Fred Hirsch talks to ecancer at the 2013 ASCO Annual Meeting in Chicago about the need for molecular testing in advanced non small cell lung cancer and advancements in treatment with crizotinib.

Dr Dirk Dr Ruysscher talks with ecancer at EMCTO 2013 in Lugano, Switzerland about chemotherapy with concurrent radiotherapy in non-small cell lung cancer. Unfortunately, only 40% of patients are able to receive concurrent radiotherapy because of the high toxicity. Patients that are able to...